But medical literature evidence suggests these same pathways may interfere with key skin functions by: Slowing fibroblast activity, reducing the production of structural proteins like collagen and elastin Decreasing cell turnover, leading to dullness and slower skin renewal Compromising the skin barrier, increasing water loss and sensitivity to environmental damage The result
Besides, both GLP-1RAs and SGLT2 inhibitors showed the obvious inhibition on neuroinflammation (123, 124)
Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, et al (2019) Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
Approximately 70% of private insurance plans cover semaglutide, making it a more accessible option for many
Mounjaro 15 mg gave an average weight loss of 22.5% in SURMOUNT-1, and Wegovy 7.2 mg gave 20.7% in STEP UP, a difference of around 1 to 2 percentage points
Discussion The results of this population based cohort study, designed to emulate a randomised controlled trial, suggest that the combined use of GLP-1 receptor agonists and SGLT-2 inhibitors is associated with a reduced risk of major adverse cardiovascular events and serious renal events, compared with using either drug class alone